Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.00% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
LXRX · Sep 30, 2025
LEXICON PHARMACEUTICALS, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001062822-25-000054General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-168.05% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
714.59% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
1.11% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
99.93% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-85.93% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
132.26% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
23.97% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History10 statesHistory building
Mar 31, 20240/7 normalizedLevel 3Jun 30, 20240/7 normalizedLevel 3Sep 30, 20240/7 normalizedLevel 3Dec 31, 20240/7 normalizedLevel 3Mar 31, 20250/8 normalizedLevel 3Jun 30, 20250/7 normalizedLevel 3Sep 30, 20250/8 normalizedLevel 3Dec 31, 20250/9 normalizedLevel 3Mar 31, 20266/8 normalizedLevel 3Jun 30, 20266/8 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 58.87%
- Current
- -168.05%
- Delta
- -226.92%
- Previous
- 1685.16%
- Current
- 714.59%
- Delta
- -970.57%
- Previous
- 0.58%
- Current
- 1.11%
- Delta
- 0.53%
- Previous
- 99.89%
- Current
- 99.93%
- Delta
- 0.04%
- Previous
- 12.94%
- Current
- -85.93%
- Delta
- -98.88%
- Previous
- 54.55%
- Current
- 132.26%
- Delta
- 77.71%
- Previous
- 11.09%
- Current
- 23.97%
- Delta
- 12.89%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · LXRX Fundamental State →Has State · LEXICON PHARMACEUTICALS, INC. →Transitioned To · LXRX INVENTORY_PRESSURE_INCREASED →Transitioned To · LXRX MARGIN_INCREASED →Transitioned To · LXRX PROFITABILITY_DECREASED →Transitioned To · LXRX R_AND_D_INTENSITY_INCREASED →Transitioned To · LXRX SBC_INTENSITY_INCREASED →Transitioned To · LXRX Fundamental State →Transitioned To · LXRX CASH_GENERATION_DECREASED →Transitioned To · LXRX GROWTH_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.